MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1053/j.gastro.2023.02.044

Медицинская библиотека · Gastroenterology · 2023

A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.

Guo Xin, Peng Yunhua, Song Qiying, Wei Jiangpeng, Wang Xinxin, Ru Yi, Xu Shenhui, Cheng Xin, Li Xiaohua, Wu Di, Chen Lubin, Wei Bo, Lv Xiaohui, Ji Gang

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND & AIMS: Diagnosing gastric cancer (GC) while the disease remains eligible for surgical resection is challenging. In view of this clinical challenge, novel and robust biomarkers for early detection thus improving prognosis of GC are necessary. The present study is to develop a blood-based long noncoding RNA (LR) signature for the early-detection of GC.

METHODS

The present 3-step study incorporated data from 2141 patients, including 888 with GC, 158 with chronic atrophic gastritis, 193 with intestinal metaplasia, 501 healthy donors, and 401 with other gastrointestinal cancers. The LR profile of stage I GC tissue samples were analyzed using transcriptomic profiling in discovery phase. The extracellular vesicle (EV)-derived LR signature was identified with a training cohort (n = 554) and validated with 2 external cohorts (n = 429 and n = 504) and a supplemental cohort (n = 69).

RESULTS

In discovery phase, one LR (GClnc1) was found to be up-regulated in both tissue and circulating EV samples with an area under the curve (AUC) of 0.9369 (95% confidence interval [CI], 0.9073-0.9664) for early-stage GC (stage I/II). The diagnostic performance of this biomarker was further confirmed in 2 external validation cohorts (Xi'an cohort, AUC: 0.8839; 95% CI: 0.8336-0.9342; Beijing cohort, AUC: 0.9018; 95% CI: 0.8597-0.9439). Moreover, EV-derived GClnc1 robustly distinguished early-stage GC from precancerous lesions (chronic atrophic gastritis and intestinal metaplasia) and GC with negative traditional gastrointestinal biomarkers (CEA, CA72-4, and CA19-9). The low levels of this biomarker in postsurgery and other gastrointestinal tumor plasma samples indicated its GC specificity.

CONCLUSIONS

EV-derived GClnc1 serves as a circulating biomarker for the early detection of GC, thus providing opportunities for curative surgery and improved survival outcomes.

Для цитирования: Guo Xin, Peng Yunhua, Song Qiying, Wei Jiangpeng, Wang Xinxin, Ru Yi, Xu Shenhui, Cheng Xin, Li Xiaohua, Wu Di, Chen Lubin, Wei Bo, Lv Xiaohui, Ji Gang. A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.. Gastroenterology. 2023. DOI: 10.1053/j.gastro.2023.02.044.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.